| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0039-6109(05)70576-4 |
| P698 | PubMed publication ID | 9194888 |
| P2093 | author name string | Tredget EE | |
| Scott PG | |||
| Ghahary A | |||
| Nedelec B | |||
| P2860 | cites work | Immunohistochemical localization of the proteoglycans decorin, biglycan and versican and transforming growth factor-beta in human post-burn hypertrophic and mature scars | Q71707970 |
| Cultured epithelial autograft: five years of clinical experience with twenty-eight patients | Q72057781 | ||
| Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor | Q72077926 | ||
| Silicone rubber substrata: a new wrinkle in the study of cell locomotion | Q72128764 | ||
| Regulation of collagen synthesis and mRNA expression in normal and hypertrophic scar fibroblasts in vitro by interferon-gamma | Q72226215 | ||
| A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids | Q72255215 | ||
| Immunolocalization of TGF-beta 1 in human hypertrophic scar and normal dermal tissues | Q72309965 | ||
| Effect of gamma-interferon on the clinical and biologic evolution of hypertrophic scars and Dupuytren's disease: an open pilot study | Q72392883 | ||
| Keloids and hypertrophic scars | Q72414712 | ||
| Skin wound healing: transforming growth factor beta antagonists decrease scarring and improve quality | Q72557412 | ||
| The response of burn scars to intralesional verapamil. Report of five cases | Q72703599 | ||
| Malignant change in keloids | Q73217154 | ||
| Transforming growth factor-beta: activity and efficacy in animal models of wound healing | Q79407014 | ||
| Interferons gamma and alpha-2b differentially regulate the expression of collagenase and tissue inhibitor of metalloproteinase-1 messenger RNA in human hypertrophic and normal dermal fibroblasts | Q79437338 | ||
| Non-pressure treatment of hypertrophic scars | Q93682577 | ||
| Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium | Q24679838 | ||
| Transforming growth factor beta in tissue fibrosis | Q28239292 | ||
| Dependence of collagen remodelling on alpha-smooth muscle actin expression by fibroblasts | Q28251091 | ||
| Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing | Q33586426 | ||
| Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets | Q33821869 | ||
| Growth factors in wound healing. Single and synergistic effects on partial thickness porcine skin wounds | Q33848658 | ||
| Dual control of cell growth by somatomedins and platelet-derived growth factor | Q34166887 | ||
| Transforming growth factor type beta induces monocyte chemotaxis and growth factor production | Q34339289 | ||
| Expression and secretion of type beta transforming growth factor by activated human macrophages | Q34341606 | ||
| An ordered sequence of events is required before BALB/c-3T3 cells become committed to DNA synthesis | Q34539190 | ||
| Evidence for a functional role of endogenously produced somatomedinlike peptides in the regulation of DNA synthesis in cultured human fibroblasts and porcine smooth muscle cells | Q34630317 | ||
| Use of cryotherapy in the treatment of keloids | Q34731318 | ||
| The metabolic effects of thermal injury | Q35193841 | ||
| Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro | Q35610349 | ||
| Platelet isoforms of platelet-derived growth factor stimulate fibroblasts to contract collagen matrices | Q35815026 | ||
| Relation between cell activity and the distribution of cytoplasmic actin and myosin | Q36204969 | ||
| Platelet-derived growth factor in chemotactic for fibroblasts | Q36205866 | ||
| A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation | Q36216808 | ||
| Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I | Q36232491 | ||
| Granulation tissue as a contractile organ. A study of structure and function | Q36271569 | ||
| Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth | Q36351780 | ||
| Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor beta | Q36352371 | ||
| The effect of stretching on formation of myofibroblasts in mouse skin | Q36653831 | ||
| Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser | Q36702717 | ||
| Hormonal control of immunoreactive somatomedin production by cultured human fibroblasts | Q37025320 | ||
| Injury induces in vivo expression of platelet-derived growth factor (PDGF) and PDGF receptor mRNAs in skin epithelial cells and PDGF mRNA in connective tissue fibroblasts | Q37376431 | ||
| A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro | Q37438001 | ||
| Cultured endothelial cells produce a platelet-derived growth factor-like protein | Q37607799 | ||
| Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy | Q37680355 | ||
| Interferons and collagen production | Q38010174 | ||
| Suppression of in vitro proliferative scar fibroblast contraction by interferon alfa-2b | Q39420449 | ||
| Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study | Q39500821 | ||
| Wound closure: evidence of cooperation between fibroblasts and collagen matrix | Q39545120 | ||
| The platelet-derived growth factor | Q39739322 | ||
| Postoperative irradiation in the prevention of keloids | Q40012402 | ||
| The neutrophilic leukocyte in wound repair a study with antineutrophil serum | Q40326337 | ||
| Fibrogenic cytokines and connective tissue production | Q40391926 | ||
| The role of extracellular matrix in postinflammatory wound healing and fibrosis | Q40694808 | ||
| Role of growth factors in cutaneous wound healing: a review | Q40806891 | ||
| Keloids Treated with Topical Injections of Triamcinolone Acetonide (Kenalog): Immediate and Long-term Results | Q40872894 | ||
| Angiogenesis and the skin: a primer | Q40949301 | ||
| An overview of the interferon system: signal transduction and mechanisms of action | Q40968135 | ||
| Adhesive contact media--an update on graft fixation and burn scar management | Q41168358 | ||
| In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors | Q41626903 | ||
| Beta 1 integrin-mediated collagen gel contraction is stimulated by PDGF. | Q41745333 | ||
| A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta | Q42804806 | ||
| A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. | Q42814129 | ||
| Smooth muscle alpha-action is a transformation-sensitive marker for mouse NIH 3T3 and Rat-2 cells | Q42814668 | ||
| Modulation of collagen gel contraction by decorin | Q42980949 | ||
| Contraction of granulation tissue in vitro: similarity to smooth muscle | Q43722441 | ||
| Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta | Q43741134 | ||
| The combined use of cryosurgery and intralesional injections of suspensions of fluorinated adrenocorticosteroids for reducing keloids and hypertrophic scars | Q43852900 | ||
| Altered cytokine production in black patients with keloids | Q43926042 | ||
| Serial casting as a technique to correct burn scar contractures. A case report | Q44018629 | ||
| Presence of modified fibroblasts in granulation tissue and their possible role in wound contraction | Q44160313 | ||
| Alteration of Hypertrophic Scars Induced by Mechanical Pressure | Q44380769 | ||
| Mast cell analyses in hypertrophic scars, hypertrophic scars treated with pressure and mature scars | Q44473680 | ||
| Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro | Q46058637 | ||
| Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping | Q46070830 | ||
| Inhibition of collagen lattice contraction by pentoxifylline and interferon-alpha, -beta, and -gamma | Q46694880 | ||
| Expression of fibronectin messenger RNA in hypertrophic and normal dermal tissues and in vitro regulation by interferon alfa-2b | Q47899903 | ||
| Regulation of collagen synthesis and messenger RNA levels in normal and hypertrophic scar fibroblasts in vitro by interferon alfa-2b | Q47899939 | ||
| Characteristics of growth, morphology, contractility, and protein expression of fibroblasts derived from keloid | Q47900011 | ||
| Alteration in cell morphology triggers transforming growth factor-beta 1, collagenase, and tissue inhibitor of metalloproteinases-I expression in normal and hypertrophic scar fibroblasts. | Q52507577 | ||
| Platelets as a source of fibroblast growth-promoting activity. | Q53597706 | ||
| Assessment of cosmetic and functional results of conservative versus surgical management of facial burns. | Q53632212 | ||
| The Histiotypic Organization of the Hypertrophic Scar in Humans | Q53937414 | ||
| Covering by a flap induces apoptosis of granulation tissue myofibroblasts and vascular cells. | Q53989083 | ||
| Artificial Dermis for Major Burns | Q56621707 | ||
| Fibroblast traction as a mechanism for collagen morphogenesis | Q59063502 | ||
| Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis. | Q64932245 | ||
| Tissue gases in human hypertrophic burn scars | Q67269016 | ||
| The use of epidermis over a keloid as an autograft after resection of the keloid | Q67497103 | ||
| Silicone patches as a supplement for pressure therapy to control hypertrophic scarring | Q68041287 | ||
| Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta | Q69004035 | ||
| Regulation of collagen gene expression in cutaneous diseases with dermal fibrosis: evidence for pretranslational control | Q69027956 | ||
| Impairment, time out of school, and time off from work after burns | Q69039237 | ||
| Collagen gene expression in keloids: analysis of collagen metabolism and type I, III, IV, and V procollagen mRNAs in keloid tissue and keloid fibroblast cultures | Q69225828 | ||
| Increased fibronectin production by cell lines from hypertrophic scar and keloid | Q69456009 | ||
| Silicone gel in scar treatment | Q69465775 | ||
| Evidence that use of a silicone gel sheet increases range of motion over burn wound contractures | Q69832281 | ||
| Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures | Q70112890 | ||
| Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-beta 1 mRNA | Q70232613 | ||
| Gas chromatography-mass spectrometry determination of 18O2 in 18O-labelled 4-hydroxyproline for measurement of collagen synthesis and intracellular degradation | Q70614856 | ||
| Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer | Q70700063 | ||
| Epidermal growth factor and insulin-like growth factor I enhance keratinocyte migration | Q70711804 | ||
| Prospective, randomized study of the efficacy of pressure garment therapy in patients with burns | Q70826017 | ||
| Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo | Q70898237 | ||
| Treatment of keloids with excision and postoperative X-ray irradiation | Q71067227 | ||
| Human dermal fibroblasts produce nitric oxide and express both constitutive and inducible nitric oxide synthase isoforms | Q71120708 | ||
| Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1 | Q71120740 | ||
| Chemical characterization and quantification of proteoglycans in human post-burn hypertrophic and mature scars | Q71149135 | ||
| Increased androgen binding in keloids: a preliminary communication | Q71231193 | ||
| Pressure therapy in the treatment of post-burn hypertrophic scar--a critical look into its usefulness and fallacies by pressure monitoring | Q71349663 | ||
| Enhanced expression of mRNA for insulin-like growth factor-1 in post-burn hypertrophic scar tissue and its fibrogenic role by dermal fibroblasts | Q71522869 | ||
| Nitric oxide activates metalloprotease enzymes in articular cartilage | Q71667841 | ||
| Pentoxifylline, pentifylline, and interferons decrease type I and III procollagen mRNA levels in dermal fibroblasts: evidence for mediation by nuclear factor 1 down-regulation | Q71669820 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 701-730 | |
| P577 | publication date | 1997-06-01 | |
| P1433 | published in | Surgical Clinics of North America | Q15765820 |
| P1476 | title | Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy | |
| P478 | volume | 77 |
| Q24683724 | A "traffic control" role for TGFbeta3: orchestrating dermal and epidermal cell motility during wound healing |
| Q77631558 | A light microscopic and immunohistochemical evaluation of scars |
| Q36167473 | A new CO2 laser technique for the treatment of pediatric hypertrophic burn scars: An observational study. |
| Q50239625 | A nude mouse model of hypertrophic scar shows morphologic and histologic characteristics of human hypertrophic scar |
| Q34387515 | A polarized multispectral imaging system for quantitative assessment of hypertrophic scars |
| Q36967147 | A/T gap tolerance in the core sequence and flanking sequence requirements of non-canonical p53 response elements |
| Q47644991 | Analysis of differentially expressed genes in keloids and normal skin with cDNA microarray |
| Q50855693 | Association between proliferative scars and in-stent restenosis. |
| Q88811634 | Autologous fat grafting in keloids and hypertrophic scars: a review |
| Q36922428 | Cellular and molecular pathology of HTS: basis for treatment |
| Q35118003 | Chemokine and chemokine receptor expression in keloid and normal fibroblasts |
| Q26778684 | Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring |
| Q61808835 | Circulating Hypoxia Responsive microRNAs (HRMs) and Wound Healing Potentials of Green Tea in Diabetic and Nondiabetic Rat Models |
| Q37408376 | Clinical and histological correlation in post-burn hypertrophic scar for pain and itching sensation |
| Q47815471 | Composite hydrogel formulations of stratifin to control MMP-1 expression in dermal fibroblasts |
| Q37222830 | Considerations for selecting the correct animal model for dermal wound-healing studies |
| Q37590206 | Control of the skin scarring response |
| Q75222593 | Cryotherapy modifies synthetic activity and differentiation of keloidal fibroblasts in vitro |
| Q51346057 | Development of a nanofibrous wound dressing with an antifibrogenic properties in vitro and in vivo model. |
| Q37527252 | Donor site wound protein synthesis correlates with length of acute hospitalization in severely burned children. |
| Q92370324 | Effect of UVA1 on hypertrophic scarring in the rabbit ear model |
| Q52923193 | Effect of triamcinolone in keloids morphological changes and cell apoptosis. |
| Q35188115 | Effects of abnormal savda munzip on the proliferation activity and migration ability of fibroblasts derived from hypertrophic scar in vitro |
| Q38781138 | Effects of epicatechin gallate on wound healing and scar formation in a full thickness incisional wound healing model in rats |
| Q92798645 | Effects of losartan and atorvastatin on the development of early posttraumatic joint stiffness in a rat model |
| Q78467536 | Elevated expression of hepatocyte and keratinocyte growth factor in cultured buccal-mucosa-derived fibroblasts compared with normal-skin-derived fibroblasts |
| Q45400761 | Elevated expression of pleiotrophin in human hypertrophic scars |
| Q36407401 | Emerging new drugs for scar reduction |
| Q34834931 | Enhanced in vivo delivery of 5-fluorouracil by ethosomal gels in rabbit ear hypertrophic scar model |
| Q35107649 | Epithelial regulation of mesenchymal tissue behavior |
| Q41870389 | Eradication of keloids: Surgical excision followed by a single injection of intralesional 5-fluorouracil and botulinum toxin |
| Q37481495 | Examination of Epithelial Mesenchymal Transition in Keloid Tissues and Possibility of Keloid Therapy Target |
| Q96304271 | Exon skipping of TGFβRI affects signalling and ECM expression in hypertrophic scar-derived fibroblasts |
| Q90042450 | Exosomes from acellular Wharton's jelly of the human umbilical cord promotes skin wound healing |
| Q42495786 | Eyelid Reconstruction with Full Thickness Skin Grafts After Carcinoma Excision. |
| Q50686436 | Fibrocytes can be reprogrammed to promote tissue remodeling capacity of dermal fibroblasts. |
| Q35085228 | Fibroproliferative scars |
| Q33238367 | Fractional photothermolysis for the treatment of surgical scars: a case report |
| Q42595498 | Functional analysis of T lymphocytes infiltrating the dermis and epidermis of post-burn hypertrophic scar tissues |
| Q50124258 | Fundamental aspects of arm repair phase in two echinoderm models |
| Q51584092 | Gene expression patterns in isolated keloid fibroblasts. |
| Q28365742 | Healing of burn wounds in transgenic mice overexpressing transforming growth factor-beta 1 in the epidermis |
| Q34911441 | Heat shock proteins modulate keloid formation |
| Q48558415 | Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells |
| Q24595036 | Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies |
| Q36154218 | Hypertrophic scarring: the greatest unmet challenge after burn injury |
| Q42514244 | Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin. |
| Q35592897 | Incidence of host site complications in periocular full thickness skin grafts |
| Q35160915 | Inflammatory mediators in wound healing |
| Q34999533 | Interferons: unapproved uses, dosages, or indications |
| Q37667048 | Intra-articular decorin influences the fibrosis genetic expression profile in a rabbit model of joint contracture |
| Q47757836 | Keloid fibroblast responsiveness to epidermal growth factor and activation of downstream intracellular signaling pathways |
| Q39977027 | Keloid formation after syndactyly release in patients with associated macrodactyly: management with methotrexate therapy |
| Q33526081 | Keloid scarring: new treatments ahead. |
| Q64989408 | Keloid treatment: what about adjuvant radiotherapy? |
| Q41882581 | Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance |
| Q34512378 | Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment |
| Q47815533 | Keratinocyte-releasable factors increased the expression of MMP1 and MMP3 in co-cultured fibroblasts under both 2D and 3D culture conditions. |
| Q33268767 | Laser treatment of keloids and hypertrophic scars |
| Q46889889 | Lipid analysis of normal dermis and hypertrophic scars |
| Q36784280 | Low-dose enalapril in the treatment of surgical cutaneous hypertrophic scar and keloid--two case reports and literature review. |
| Q47281007 | Macrophages in keloid are potent at promoting the differentiation and function of regulatory T cells |
| Q34699606 | Management of keloids and hypertrophic scars: current and emerging options |
| Q35251059 | MicroRNA 181b regulates decorin production by dermal fibroblasts and may be a potential therapy for hypertrophic scar |
| Q64233364 | MicroRNA-205-5p regulates extracellular matrix production in hyperplastic scars by targeting Smad2 |
| Q44833827 | MicroRNA-21 inhibits mitochondria-mediated apoptosis in keloid |
| Q64967937 | MicroRNA‑486‑5p inhibits the growth of human hypertrophic scar fibroblasts by regulating Smad2 expression. |
| Q27011291 | Musculoskeletal regeneration and its implications for the treatment of tendinopathy |
| Q53207783 | Myofibroblast cells are preferentially expressed early in a rabbit model of joint contracture. |
| Q34176422 | Myofibroblast numbers are elevated in human elbow capsules after trauma |
| Q38459769 | Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts in vitro |
| Q35786221 | Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts |
| Q33725897 | Overview about the keloid scars and the elaboration of a non-invasive, unconventional treatment |
| Q46773510 | Panx1 regulates cellular properties of keratinocytes and dermal fibroblasts in skin development and wound healing |
| Q33936938 | Pathophysiology and treatment of fibroproliferative disorders following thermal injury |
| Q24803687 | Phenotypic differences between dermal fibroblasts from different body sites determine their responses to tension and TGFbeta1. |
| Q45030052 | Phosphorylation of extracellular signal-regulated protein kinase in cultured keloid fibroblasts when stimulated by platelet-derived growth factor BB. |
| Q34475825 | Physiology and healing dynamics of chronic cutaneous wounds |
| Q38630692 | Potential benefits of pentoxifylline on wound healing. |
| Q24650485 | Prevention and treatment of excessive dermal scarring |
| Q54967102 | Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids. |
| Q33605750 | Regulation of scar formation by vascular endothelial growth factor |
| Q42710453 | Resveratrol inhibits fibrogenesis and induces apoptosis in keloid fibroblasts |
| Q40666079 | Role of IGF system of mitogens in the induction of fibroblast proliferation by keloid-derived keratinocytes in vitro |
| Q35907248 | Savior of post-blepharoepicanthoplasty scarring: Novel use of a low-fluence 1064-nm Q-switched Nd:YAG laser |
| Q52837772 | Serum Decorin, Interleukin-1β, and Transforming Growth Factor-β Predict Hypertrophic Scarring Postburn. |
| Q45896697 | Simultaneous silencing of TGF-β1 and COX-2 reduces human skin hypertrophic scar through activation of fibroblast apoptosis |
| Q36620519 | Smad ubiquitination regulatory factor 2 expression is enhanced in hypertrophic scar fibroblasts from burned children |
| Q36516939 | Smallpox vaccination site complications |
| Q55504896 | Spontaneous healing and scar control following enzymatic debridement of deep second-degree burns. |
| Q39347029 | Stem Cells and Tissue Engineering: Regeneration of the Skin and Its Contents |
| Q64253660 | The Dynamics of the Skin's Immune System |
| Q42355561 | The Importance of Mast Cells in Dermal Scarring |
| Q36675464 | The alarmin HMGB-1 influences healing outcomes in fetal skin wounds |
| Q42067251 | The anti-motility signaling mechanism of TGFβ3 that controls cell traffic during skin wound healing |
| Q46719515 | The mast cell stabilizer ketotifen prevents development of excessive skin wound contraction and fibrosis in red Duroc pigs |
| Q28073238 | The molecular basis of hypertrophic scars |
| Q38090543 | The molecular mechanism of hypertrophic scar |
| Q36890002 | The role of stratifin in fibroblast-keratinocyte interaction |
| Q34645189 | The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. |
| Q33927400 | The use of silicone gel sheeting in the management of hypertrophic and keloid scars |
| Q35927177 | Thermal injury to the hand: review of the literature |
| Q53135770 | Topical application of a film-forming emulgel dressing that controls the release of stratifin and acetylsalicylic acid and improves/prevents hypertrophic scarring. |
| Q51715800 | Tretinoin reverses upregulation of matrix metalloproteinase-13 in human keloid-derived fibroblasts. |
| Q38637144 | Ultrastructural differentiation of abnormal scars |
| Q37565382 | Upregulation of proinflammatory genes in skin lesions may be the cause of keloid formation (Review). |
| Q50077526 | Wound Healing Concepts in Clinical Practice of OMFS. |
| Q79866462 | Wound healing |
| Q79242513 | [Hyperplastic scars and keloids. Part I: basics and prevention] |
| Q84100002 | [Plastic reconstructive surgery for burn injuries] |
Search more.